...
首页> 外文期刊>Vaccine >A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination
【24h】

A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination

机译:对乙型肝炎疫苗接种反应较差的成年人的管理选择的系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

An estimated 5-10% of adults do not seroconvert after a three-dose primary course of hepatitis B vaccines, and are considered non-responders. Many approaches have been used to induce immunity in healthy adult non-responders, but few studies have compared their relative effectiveness. We conducted a systematic review and meta-analysis of seroconversion rates after additional doses of four approaches: 20 mcg or 40 mcg intramuscular (IM), and 5 mcg or 20 mcg intradermal (ID). The search identified 13 articles encompassing 16 studies (N = 1067) that met the eligibility criteria. Seroconversion rates after additional doses of each approach were pooled and estimated. After one additional dose, the four approaches produced very similar seroconversion rates and we did not find any evidence to support the use of 40 mcg IM in healthy adults. (C) 2015 Elsevier Ltd. All rights reserved.
机译:估计有5-10%的成年人在服用三剂乙肝疫苗后没有血清转换,因此被认为没有反应。在健康的成年无反应者中已经使用了许多方法来诱导免疫,但是很少有研究比较它们的相对有效性。在另外四种方法剂量后,我们对血清转化率进行了系统的回顾和荟萃分析:20 mcg或40 mcg肌内(IM)和5 mcg或20 mcg皮内(ID)。搜索确定了13篇文章,其中包括16项符合资格标准的研究(N = 1067)。汇总并估算每种方法额外剂量后的血清转化率。再加一剂后,四种方法产生的血清转化率非常相似,我们没有发现任何证据支持在健康成年人中使用40 mcg IM。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号